The Affiliated Zhongshan Hospital of Dalian University
Welcome,         Profile    Billing    Logout  
 5 Trials 
13 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zhou, Jun
NCT05223907: Safety and Efficacy of Maintenance of Etomidate in General Anesthesia

Completed
4
1080
RoW
Etomidate, Etomidate Injectable Emulsion, Yituomizhi, H20020511, WS-400(X-338)-2002-2015Z,YT211101, Propofol, Diprivan, JX20060102,H20080473,RW981
Henan Provincial People's Hospital
General Anesthesia
12/22
12/22
NCT05386056: Pembrolizumab and Photodynamic Therapy in Previously Treated Metastatic Esophageal Squamous Cell Carcinoma

Not yet recruiting
2
54
RoW
Pembrolizumab, MK-3475, Sinoporphyrin Sodium, DVDMS, Photodynamic therapy, PDT
Peking University
Esophageal Squamous Cell Carcinoma
10/23
06/24
MA-HCC-II-021, NCT06360042: Anti-PD-1/PD-L1 Combined With Anti-angiogenic Agents as First-line Treatment for Unresectable HCC

Recruiting
2
111
RoW
Adebrelimab plus Apatinib, Adebrelimab plus Bevacizumab, Camrelizumab plus Apatinib
Peking University Cancer Hospital & Institute
Unresectable Hepatocellular Carcinoma
03/27
03/28
OBU-HCC-II-001, NCT06405061: Evaluation of Effectiveness and Safety of HAIC in Combination With Adebrelimab and Bevacizumab for Potentially Resectable Hepatocellular Carcinoma

Recruiting
2
40
RoW
Adebrelimab, Bevacizumab, HAIC
Tianjin Medical University Cancer Institute and Hospital
Adebrelimab, Hepatocellular Carcinoma
05/25
08/27
TQB2102-Ib/II-01, NCT06431490: A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer

Recruiting
1/2
103
RoW
TQB2102 for injection
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Biliary Tract Cancer
05/25
12/25
NCT04467853: A Clinical Study to Evaluate CAR-T Cell-based Medicinal Product in the Treatment of Advanced Solid Tumors

Terminated
1
34
RoW
LCAR-C18S cells
Shanghai East Hospital, Nanjing Legend Biotech Co.
Solid Tumors, Adult
07/23
07/23
NCT06197178: A Study of LCAR-G08 in Subjects With Advanced Gastrointestinal Tumors Expressing Guanylyl Cyclase C (GCC)

Recruiting
1
42
RoW
LCAR-G08 cells
Peking University, Nanjing Legend Biotech Co.
Advanced Gastrointestinal Tumors
11/25
03/28
NCT05621486: A Clinical Study to Evaluate B4T2-001 CAR T Cells in the Treatment of Advanced Solid Tumors

Active, not recruiting
1
36
RoW
B4T2-001 Autologous CAR T cells
Shanghai East Hospital, Bio4T2 LLC
Advanced Solid Tumor
12/24
12/26
NCT06072989: Repeat Intravenous Infusions of B4T2-001 CAR-T Without Lymphodepleting Chemotherapy for Solid Tumors

Recruiting
1
24
RoW
B4T2-001 autologous CAR-T
Shanghai East Hospital, Bio4T2 LLC
Advanced Solid Tumor
03/25
03/27
NCT06425406: Application of HFNC for the Prevention of Hypoxemia During Perioperative Anesthetic-induced Intubation in Children: A Randomized Controlled Clinical Trial

Recruiting
N/A
48
RoW
high-flow nasal cannula
Henan Provincial People's Hospital
High-flow Nasal Cannula, Children, Pre-oxygenation
05/25
05/25
NCT06471491: Driving Pressure-guided Positive End-expiratory Pressure to Prevent Postoperative Atelectasis in Obese Children: a Prospective, Randomized Controlled Clinical Trial

Recruiting
N/A
40
RoW
Driving pressure-guided positive end-expiratory pressure
Henan Provincial People's Hospital
Driving Pressure, Positive End-expiratory Pressure, Postoperative Atelectasis, Obese
05/25
05/25
NCT06016790: Exploring a Breast Cancer Early Screening Model Based on cfDNA

Completed
N/A
792
RoW
cfDNA sequencing
Second Affiliated Hospital, School of Medicine, Zhejiang University, OmixScience Institute
Breast Cancer, Breast Fibroadenoma, Breast Hypoplasia
12/23
10/24
NCT03356236: Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma Following Local Ablation

Recruiting
N/A
828
RoW
Yue Han
Hepatocarcinoma
08/24
12/24

Download Options